-
1h 46sPart 2 | Session 5 Plenary session 8 – Devices in HF: time to reassess their place?
-
1h 1m 52sPart 2 | Session 7 Plenary session 9 – New technologies for HF management
-
1h 2m 8sPart 2 | Session 8 Plenary session 10 – Special Populations
-
1h 54sPart 1 | Session 1 Plenary session 1 – Recent guideline updates in HF
-
1h 8m 32sPart 1 | Session 3 Plenary session 2 – GDMT in the clinical setting
-
51m 41sPart 1 | Session 4 Special Live Interactive Session – Management of ATTR-CM
-
57m 43sPart 1 | Session 6 Plenary session 3 – SGLT2i in clinical practice
-
1h 1m 49sPart 1 | Session 8 Plenary session 4 – Obesity and weight management in HF
-
56m 50sPart 1 | Session 10 Plenary session 5 – Worsening and acute heart failure
-
1h 1m 56sPart 2 | Session 2 Plenary session 6 – Iron deficiency: the totality of evidence
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure 2023.
A thoughtfully curated programme supported the exploration of how leading experts are implementing the new heart failure guidelines into clinical practice and showed the latest information on patient profiling in heart failure for tailoring medical therapy.
This event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Harriette Van Spall
Associate Professor of Medicine, Director of E-Health and Virtual Care
Dr Harriette Van Spall is an internationally known cardiologist, research methodologist, and senior scientist. She serves as an Associate Professor of Medicine at McMaster University, a Senior Scientist at the Population Health Research Institute, and Director of Implementation Science at the Baim Institute for Clinical Research in Boston.
Academic history
Dr Van Spall completed her BSc and MD at the University of Toronto, followed by residency and fellowship training in internal medicine and…
Brenda Moura
Cardiologist
Dr Brenda Moura is a cardiologist at Military Hospital, Porto, PT.
Her areas of interest include cardio-vascular risk, clinical cardiology, heart failure and cardio-oncology.
In 2020, Dr Moura was president of the Portuguese Congress of Cardiology.
Gerasimos Filippatos
Professor of Cardiology
Prof Gerasimos Filippatos is a Professor of Cardiology and Cardiologist at National and Kapodistrian University of Athens, Athens, GR.
He studied Medicine at the University of Patras, and earned his doctorate Cum Laude from the University of Athens.
Prof Filippatos is Past President of the Heart Failure Association (HFA) of the European Society of Cardiology and he has published over 600 articles in peer-reviewed journals and authored more than 30 book chapters.
Michael Böhm
Director Internal Medicine Clinic III, Angiology and Intensive Care Medicine
Academic History
Michael Böhm studied medicine from 1977 to 1984 at the Medical School of Hannover (MHH), Germany. During 1979–1981, he completed his doctoral thesis at the Centre for Toxicology and Pharmacology at MHH. He then spent time (1982) at the Tufts University, Boston, USA. Following that, from 1982–1984 he worked as a scientific assistant at the University Hospital Hamburg-Eppendorf (division of general pharmacology). From 1986 to 1993, he trained in internal medicine and cardiology at the Medizinische Klinik I, Klinikum Großhadern, of the Ludwig-Maximilians-Universität München. In 1993 he obtained his habilitation and became assistant professor of internal medicine/cardiology at the Universität zu Köln (University of Cologne). Between 1995 and 2000 he held a C3-Professorship there; in 2000 he was appointed to a C4-Professorship for Internal Medicine with focus on Cardiology/Angiology at the Saarland University, Homburg/Saar, Germany — at which time he became…
João Pedro Ferreira
Professor
Dr João Ferreira is a Professor at the Faculty of Medicine of the University of Porto, Porto, PT.
He is also a colaborator with the Clinical Research Center, Nancy, FR.
Dr Ferreira's areas of research include hypertension, cardiac arrest, biomarkers and internal medicine.
Comments